VIVOSTART Trademark
Trademark Overview
On Wednesday, July 6, 2022, a trademark application was filed for VIVOSTART with the United States Patent and Trademark Office. The USPTO has given the VIVOSTART trademark a serial number of 97490617. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, August 13, 2024. This trademark is owned by BioIVT Holdings, LLC. The VIVOSTART trademark is filed in the Chemical Products, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:
Distribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood
Cells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use
Manufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research
General Information
| Serial Number | 97490617 |
| Word Mark | VIVOSTART |
| Filing Date | Wednesday, July 6, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, August 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 10, 2023 |
Trademark Statements
| Goods and Services | Distribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood |
| Pseudo Mark | VIVO START |
| Goods and Services | Cells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use |
| Goods and Services | Manufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 25, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 25, 2022 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 25, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | BioIVT Holdings, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Westbury, NY 11590 |
| Party Name | BioIVT Holdings, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Westbury, NY 11590 |
Trademark Events
| Event Date | Event Description |
| Saturday, July 9, 2022 | NEW APPLICATION ENTERED |
| Monday, July 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 20, 2023 | ASSIGNED TO EXAMINER |
| Friday, April 21, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, April 21, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, April 21, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 20, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 10, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 10, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 5, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, June 5, 2024 | SOU EXTENSION 1 FILED |
| Thursday, June 6, 2024 | TEAS PETITION TO REVIVE RECEIVED |
| Thursday, June 6, 2024 | PETITION TO REVIVE-GRANTED |
| Thursday, June 6, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, June 6, 2024 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Monday, August 12, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, August 14, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, August 14, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 26, 2024 | SOU TEAS EXTENSION RECEIVED |
